QCM
IRWD icon

Quantinno Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Quantinno Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$455K Buy
129,703
+10,810
+9% +$44.3K ﹤0.01% 2780
2025
Q4 		$401K Buy
+118,893
New +$309K ﹤0.01% 2635
2024
Q4 		– Sell
-19,191
Closed -$79.1K – 1663
2024
Q3 		$79.1K Buy
19,191
+5,482
+40% +$29.5K ﹤0.01% 1449
2024
Q2 		$89.4K Buy
+13,709
New +$97K ﹤0.01% 1300
2019
Q1 		– Sell
-15,054
Closed -$131K – 423
2018
Q4 		$131K Buy
+15,054
New +$173K 0.11% 334

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Quantinno Capital Management's IRWD Position: Q1 2026 in Review

Quantinno Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 9.1% in Q1 2026, buying an estimated $44.3K and bringing the position to 129,703 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #2780.

Quantinno Capital Management first reported a position in IRWD in Q4 2018 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Quantinno Capital Management held 129,703 shares of Ironwood Pharmaceuticals worth $455K as of Q1 2026.
  • Quantinno Capital Management bought 10,810 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $44.3K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2780 holding.
  • Quantinno Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2018 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.